Next Article in Journal
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore
Next Article in Special Issue
Targeting NMDA Receptor Complex in Management of Epilepsy
Previous Article in Journal
64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window
Previous Article in Special Issue
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(8), 997; https://doi.org/10.3390/ph15080997
Action Date Notes Link
article pdf uploaded. 13 August 2022 11:56 CEST Version of Record https://www.mdpi.com/1424-8247/15/8/997/pdf-vor
article supplementary file uploaded. 13 August 2022 11:56 CEST - https://www.mdpi.com/1424-8247/15/8/997#supplementary
article pdf uploaded. 16 August 2022 10:47 CEST Updated version of record https://www.mdpi.com/1424-8247/15/8/997/pdf-vor
article xml file uploaded 17 August 2022 11:00 CEST Original file -
article xml uploaded. 17 August 2022 11:00 CEST Update -
article pdf uploaded. 17 August 2022 11:00 CEST Updated version of record https://www.mdpi.com/1424-8247/15/8/997/pdf-vor
article html file updated 17 August 2022 11:02 CEST Original file -
article xml file uploaded 19 August 2022 05:15 CEST Update -
article xml uploaded. 19 August 2022 05:15 CEST Update https://www.mdpi.com/1424-8247/15/8/997/xml
article pdf uploaded. 19 August 2022 05:15 CEST Updated version of record https://www.mdpi.com/1424-8247/15/8/997/pdf
article html file updated 19 August 2022 05:16 CEST Update https://www.mdpi.com/1424-8247/15/8/997/html
Back to TopTop